Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H17NO3 |
| Molecular Weight | 283.3218 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(CCNC(=O)\C=C\C2=CC=CC=C2)C=C1O
InChI
InChIKey=OICMBMJTQCLGNP-VQHVLOKHSA-N
InChI=1S/C17H17NO3/c19-15-8-6-14(12-16(15)20)10-11-18-17(21)9-7-13-4-2-1-3-5-13/h1-9,12,19-20H,10-11H2,(H,18,21)/b9-7+
| Molecular Formula | C17H17NO3 |
| Molecular Weight | 283.3218 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:47:39 GMT 2025
by
admin
on
Mon Mar 31 21:47:39 GMT 2025
|
| Record UNII |
3FD7ZX4Y88
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20762133
Created by
admin on Mon Mar 31 21:47:39 GMT 2025 , Edited by admin on Mon Mar 31 21:47:39 GMT 2025
|
PRIMARY | |||
|
24285615
Created by
admin on Mon Mar 31 21:47:39 GMT 2025 , Edited by admin on Mon Mar 31 21:47:39 GMT 2025
|
PRIMARY | |||
|
103188-45-0
Created by
admin on Mon Mar 31 21:47:39 GMT 2025 , Edited by admin on Mon Mar 31 21:47:39 GMT 2025
|
PRIMARY | |||
|
105954-99-2
Created by
admin on Mon Mar 31 21:47:39 GMT 2025 , Edited by admin on Mon Mar 31 21:47:39 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
3FD7ZX4Y88
Created by
admin on Mon Mar 31 21:47:39 GMT 2025 , Edited by admin on Mon Mar 31 21:47:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations < 0.05 uM in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N- affeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
90 uM IC50 vs in vitro prostaglandin synthesis
|
